Procedures for Ordering and Distributing COVID-19 Vaccines

Stay informed about the COVID-19 pandemic in France and around the world

Updates, Q&As, expert interviews... everything you need to know about the novel coronavirus (SARS-CoV-2) and COVID-19 in France and around the world

Learn more

In this article

A compter du 1er décembre 2023, le service client support via formulaire de contact pour la commande de vaccins Covid-19 prend fin. Ce service a été mis à disposition des officines pour répondre aux questions sur la prise de commande des vaccins Covid-19. Nous précisons que l’outil de commande reste toujours ouvert les lundis et mardis de chaque semaine. 

En ce sens, merci de bien vouloir consulter la base documentaire enrichie et actualisée, mise à votre disposition dans les rubriques "besoin d'aide ?" et "documentation et références".

Dans le cadre de la crise sanitaire de la COVID-19, ce service permet aux officines de commander des vaccins pour elles-mêmes ainsi que pour les professionnels de santé de ville et établissements qui leur sont rattachés.

Accès rapide

Vaccine orders and distribution are handled as follows (unless otherwise notified):

  • Return to weekly ordering starting with the session on March 30 and 31, 2026: ordering is open to pharmacies each week during a specific period, usually from Monday to Tuesday at 11:00 PM;

  • Products ordered during a Monday or Tuesday ordering session will be delivered between Thursday and Friday of the following week, i.e., 10 days later, barring exceptions;

  • The pharmacy can view its order confirmation directly on the ordering tool starting the day after the ordering session closes (usually Wednesday at 6:00 PM).

COVID-19 Vaccine Distribution Process

Flux de distribution des vaccins COVID

Vaccines

Unless otherwise announced by DGS-Urgent, pharmacies may order vaccine vials for themselves and their affiliated healthcare providers according to the procedures outlined below.

Vaccines Comirnaty LP.8.1 (Pfizer-BioNTech)
Ready-to-use
12 years and older		 Comirnaty LP.8.1 (Pfizer-BioNTech)
Ready-to-use
5–11 years		 Comirnaty LP.8.1 (Pfizer-BioNTech)
for dilution
6 months – 4 years
Physicians

The number of vials is limited to 20 vials per healthcare provider, while ensuring that no unused stock is accumulated, with the exception of:

- Pharmacists: 30 vials

- Nursing homes: 40 vials

 Limited to 3 vials per healthcare provider, ensuring no unused stock is accumulated Limited to 2 vials per healthcare provider, while ensuring that no unused stock is accumulated
Nurses, midwives Limited to 1 vial per healthcare provider, ensuring no unused stock is accumulated Limited to 1 vial per healthcare provider, ensuring no unused stock is accumulated
Pharmacists
Dentists Not available for order Not available for order
MSP, CDS, LBM
FAM, MAS, EHPAD, USLD, and assisted living facilities
SST
SSU
PMI Not available for order Limited to 1 vial per healthcare provider, ensuring no unused stock is accumulated Limited to 1 vial per healthcare provider, while ensuring that no unused stock is accumulated

Age for administration Dilution required Unit dose Number of doses per vial
Comirnaty LP.8.1 (30 micrograms)/dose, injectable dispersion Ages 12 and older NO 0.3 mL 6 doses
Comirnaty LP.8.1 (10 micrograms)/dose injectable dispersion Ages 5 to 11 inclusive NO 0.3 mL 6 doses
Comirnaty LP.8.1 (3 micrograms)/dose concentrate for injection From 6 months to 4 years, inclusive YES 0.3 mL 3 doses

Medical devices

Medical devices for the administration and reconstitution of COVID-19 vaccines are no longer distributed by Santé publique France.

Medical devices to be purchased by pharmacists must comply with the summaries of product characteristics for Comirnaty® vaccines available in the public drug database.